Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003080983 | SCV003485259 | uncertain significance | not provided | 2022-05-19 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. This variant has not been reported in the literature in individuals affected with HERC1-related conditions. This variant is present in population databases (rs753441944, gnomAD 0.001%). This sequence change replaces threonine, which is neutral and polar, with arginine, which is basic and polar, at codon 1318 of the HERC1 protein (p.Thr1318Arg). |
3billion | RCV004725529 | SCV005328978 | likely benign | Macrocephaly, dysmorphic facies, and psychomotor retardation | 2024-09-20 | criteria provided, single submitter | clinical testing | The homozygous variant was found in patients diagnosed with another variant in a different gene, with no symptoms related to the gene containing the homozygous variant. |